According to CNBC, Apple rose 1% after unveiling its HomeView smart home hub, which is powered by Apple Intelligence with Siri AI and is designed for multiple people in a household using facial recognition to show relevant information. Meta Platforms climbed more than 2% for a second day after rolling out its Muse Wonder artificial intelligence model, and Truist raised its price target to $1,000 from $763. Bumble surged 56% after saying it will be acquired by Ithaca Holdings in an all-cash deal valuing the company at $1.3 billion.

Memory chip stocks fell after a weak overnight session in South Korea, as concerns about valuations increased following CXMT's plans to launch a new, more powerful chip by the end of 2026. U.S.-listed SK hynix shares dropped 4%, while Western Digital and Seagate each fell 2%; Micron lost 4.9% and Sandisk declined 2.7%. AI infrastructure stocks also slid, with Applied Materials down 6%, Lam Research and Teradyne each off more than 3%, Lumentum down more than 2%, and the iShares AI Innovation and Tech ETF (BAI) down nearly 3%.

Fermi jumped 17% after signing a credit support agreement with Advanced Micro Devices for the first phase of its Project Matador energy and AI buildout in Texas. The companies also signed a deal outlining a partnership and a framework to expand up to 650 megawatts of gross power capacity. JPMorgan Chase was slightly higher after raising its net interest income outlook for the year, though gains were limited after third-quarter earnings and revenue missed analyst expectations. Wells Fargo fell 1% after mixed third-quarter results, Goldman Sachs rose nearly 1% after reporting third-quarter revenue of $18.68 billion versus an LSEG estimate of $16.71 billion, and Johnson & Johnson slid more than 6% after stronger-than-expected third-quarter results were offset by soft medical device sales and MedTech revenue of $8.64 billion, below a StreetAccount estimate of $8.74 billion. Domino's Pizza fell 3% after third-quarter results failed to impress investors, Syndax Pharmaceuticals tumbled 16% after axatilimab missed its primary endpoint in a Phase 2 trial for idiopathic pulmonary fibrosis, Six Flags plunged 16% after a man died and others were injured in a roller coaster incident in Georgia, and UnitedHealth was last up less than 1% after posting third-quarter results that beat analyst expectations.